Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WM-115 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1717 | 570 | 0.2863 | 0.2911 | 0.3320 | 0.3460 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 915 | 46 | 0.6656 | 0.7554 | 0.0503 | 0.0454 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 1078 | 44 | 0.7919 | 0.7554 | 0.0408 | 0.0454 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 896 | 69 | 0.6334 | 0.6145 | 0.0770 | 0.0615 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 862 | 273 | 0.4511 | 0.3972 | 0.3167 | 0.3126 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 1667 | 411 | 0.3135 | 0.3432 | 0.2466 | 0.2379 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1841 | 377 | 0.3655 | 0.3432 | 0.2048 | 0.2379 |
MMAC-SF | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 939 | 30 | 0.6962 | 0.7322 | 0.0319 | 0.0524 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 1905 | 500 | 0.3507 | 0.3432 | 0.2625 | 0.2379 |
A-375 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 4259 | 158 | 0.2077 | 0.1953 | 0.0371 | 0.0349 |
WM-115 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 3002 | 210 | 0.6970 | 0.7092 | 0.0700 | 0.0818 |
MMAC-SF | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 753 | 46 | 0.5415 | 0.7322 | 0.0611 | 0.0524 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 1983 | 575 | 0.3515 | 0.3661 | 0.2900 | 0.2461 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 2680 | 77 | 0.1318 | 0.1200 | 0.0287 | 0.0313 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 1963 | 519 | 0.3605 | 0.3661 | 0.2644 | 0.2461 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 1897 | 349 | 0.3864 | 0.3661 | 0.1840 | 0.2461 |
A-375 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 3957 | 137 | 0.1934 | 0.1953 | 0.0346 | 0.0349 |
WM-115 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 3197 | 306 | 0.7217 | 0.7092 | 0.0957 | 0.0818 |
MMAC-SF | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 1338 | 86 | 0.9589 | 0.7322 | 0.0643 | 0.0524 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 885 | 43 | 0.6449 | 0.7202 | 0.0486 | 0.0513 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 3532 | 218 | 0.8273 | 0.8638 | 0.0617 | 0.0643 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 2034 | 549 | 0.3707 | 0.3578 | 0.2699 | 0.2762 |
MMAC-SF | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 1049 | 69 | 0.7506 | 0.6857 | 0.0658 | 0.0645 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 1706 | 704 | 0.1431 | 0.1375 | 0.4127 | 0.4603 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 1621 | 824 | 0.1139 | 0.1375 | 0.5083 | 0.4603 |